|
Report No. : |
333989 |
|
Report Date : |
25.07.2015 |
IDENTIFICATION DETAILS
|
Name : |
KOSHIRO CO LTD |
|
|
|
|
Registered Office : |
2-5-8 Doshomachi Chuoku
Osaka 541-0045 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
30.06.2015 |
|
|
|
|
Date of Incorporation : |
March 1947 |
|
|
|
|
Legal Form : |
Limited
Company |
|
|
|
|
Line of Business : |
Subject
is manufactures pharmaceutical crude drugs, cosmetics, health foods |
|
|
|
|
No. of Employee : |
43 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
COMPANY NAME
KOSHIRO CO LTD
REGD NAME
Koshiro Seiyaku KK
MAIN OFFICE
2-5-8 Doshomachi
Chuoku Osaka 541-0045 JAPAN
Tel:
06-6231-1803 Fax: 06-6227-0187
URL
http://www.koshiroseiyaku.co.jp
E-Mail
address: (thru the URL)
ACTIVITIES
Mfg
crude drugs, cosmetics, health foods, other
BRANCHES
Osaka
(warehouse)
OVERSEAS
China,
Taiwan, Korea, other (--business partners)
FACTORIES
Kameoka
(Kyoto)
OFFICERS
TADAAKI
KOSHIRO, PRES
Masami
Karikura, dir
Noriko
Koshiro, dir
Yen
Amount: In million Yen, unless
otherwise stated
SUMMARY
FINANCES FAIR A/SALES Yen 2,934 M
PAYMENTSREGULAR CAPITAL Yen
100 M
TREND SLOW WORTH Yen 8,447 M
STARTED 1947 EMPLOYES 43
COMMENT
MFR OF CRUDE DRUGS, COSMETICS,
HEALTH FOODS, OTHER.
FINANCIAL SITUATION CONSIDERED
FAIR AND GOOD FOR
ORDINARY BUSINESS ENGAGEMENTS.
MAX
CREDIT LIMIT: ESTIMATED AT YEN 155.9 MILLION, ON 30 DAYS NORMAL TERMS.
HIGHLIGHTS
This is a specialized mfr of pharmaceuticals, crude drugs,
cosmetics, health foods, other. Goods
are both imported and exported. Clients
include pharmaceutical makers, wholesalers, others.
FINANCIAL INFORMATION
The sales volume for Jun/2014 fiscal term amounted to Yen
2,934 million, a 3% down from Yen 3,020 million in the previous term. The recurring profit was posted at Yen 642
million and the net profit at Yen 382 million, respectively, compared with Yen
566 million recurring profit and Yen 302 million net profit, respectively, a
year ago.
For the term that ended Jun 2015 the recurring profit was
projected at Yen 670 million and the net profit at Yen 405 million, respectively,
on a 5% rise in turnover, to Yen 3,080 million.
Final results are yet to be released.
The financial situation is considered FAIR and good for
ORDINARY business engagements. Max
credit limit is estimated at Yen 155.9 million, on 30 days normal terms.
REGISTRATION
Date Registered: Mar 1947
Legal Status: Limited Company (Kabushiki Kaisha)
Authorized: 800,000 shares
Issued:
200,000 shares
Sum: Yen 100 million
Major shareholders (%): Tadaaki Koshiro & families
(--100)
No. of shareholders: 5
Nothing
detrimental is known as to the commercial morality of executives.
OPERATION
Activities: Manufactures pharmaceutical crude
drugs, cosmetics, health foods, other (--100%)
Clients: [Mfrs, wholesalers] Taiho Pharmaceutical,
Shionogi Pharmaceutical, Astellas Pharmaceutical, Taisho Pharmaceutical,
Shiseido, Suntory Holdings, other
No. of
accounts: 300
Domestic
areas of activities: Nationwide
Suppliers: [Mfrs, wholesalers] Penreco (USA),
Sojitz Corp, Nihon Yoho, other
Imports from USA, China, Taiwan,
Korea, other
Payment record: Regular
Location:
Business area in Osaka. Office premises
at the caption address are owned and maintained satisfactorily.
Bank References:
MUFG
(Osaka)
SMBC
(Bingomachi)
Relations:
Satisfactory
FINANCES
(In Million Yen)
|
Terms Ending: |
30/06/2015 |
30/06/2014 |
30/06/2013 |
30/06/2012 |
|
|
Annual
Sales |
|
3,080 |
2,934 |
3,020 |
3,175 |
|
Recur.
Profit |
|
670 |
642 |
566 |
|
|
Net
Profit |
|
405 |
382 |
302 |
368 |
|
Total
Assets |
|
|
9,501 |
9,004 |
8,870 |
|
Current
Assets |
|
|
6,850 |
6,402 |
|
|
Current
Liabs |
|
|
811 |
822 |
|
|
Net
Worth |
|
|
8,447 |
8,074 |
7,832 |
|
Capital,
Paid-Up |
|
|
100 |
100 |
100 |
|
Div.Ttl
in Million (¥) |
|
|
9.97 |
60 |
10 |
|
<Analytical Data> |
|
(%) |
(%) |
(%) |
(%) |
|
S.Growth Rate |
|
4.98 |
-2.85 |
-4.88 |
-9.31 |
|
Current Ratio |
|
.. |
844.64 |
778.83 |
.. |
|
N.Worth Ratio |
|
.. |
88.91 |
89.67 |
88.30 |
|
R.Profit/Sales |
|
21.75 |
21.88 |
18.74 |
.. |
|
N.Profit/Sales |
|
13.15 |
13.02 |
10.00 |
11.59 |
|
Return On Equity |
|
.. |
4.52 |
3.74 |
4.70 |
Notes:
Forecast (or estimated) figures for the 30/06/2015 fiscal term.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.